![](/img/cover-not-exists.png)
A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer
O’Donnell, Michael A., Singh, Sharwan, Sood, Rajeev, Amlani, Jitendra, Krishnamoorthy, H., Shukla, Ketan, Mohanty, Nayan, Bhatia, Sushil, Chakraborty, Bhaswat, Desai, Nirav, Modi, Rajiv, Shukla, ChandLanguage:
english
Journal:
Bladder Cancer
DOI:
10.3233/BLC-190211
Date:
July, 2019
File:
PDF, 585 KB
english, 2019